18 September 2018
Founded in 2018, we at Aidplex have rapidly emerged as trailblazers in the healthcare industry, introducing innovative and life-changing technologies to address critical medical challenges. With a dedicated team of experts and a vision for revolutionizing patient care, we are making significant strides towards shaping the future of medical technology.
19 March 2019
Our debut product, 3D-printed splints, showcased our commitment to cutting-edge technology and patient-centric solutions. These bespoke splints offered enhanced comfort and support, heralding a new era in personalized orthopedic care.
24 June 2020
ScolioSense made a groundbreaking debut, designed to revolutionize scoliosis treatment tracking. With its advanced sensors and real-time data analysis, we empower both children and healthcare providers to track progress more efficiently and make informed decisions for optimized treatment outcomes.
11 May 2023
Aidplex successfully secured a funding round of $340K, with investments from TECS Capital VC and angel investors from the US and the EU. This financial infusion propelled our research, development, and market expansion, enabling us to complete the development, regulatory approval, initial marketing, and pilot testing of ScolioSense.
Q3 2023
After receiving regulatory approvals by achieving compliance with ISO13485 and being granted the CE mark, we have solidified our commitment to high standards in medical device quality and safety. With these milestones achieved, ScolioSense is now poised for commercialization. We have already garnered strong interest from orthopedic clinicians and brace manufacturers eager to integrate ScolioSense into their scoliosis treatment programs and provide their patients with cutting-edge monitoring solutions.
Q1 2024
On the commercial front, we have made significant strides in expanding our market presence. We secured our first customers in Greece, marking a critical milestone in our local outreach.
Q2 2024
We solidified a 3-year contract with our Nordic partners, which not only strengthens our foothold in the Northern European market but also opens up collaborative opportunities for future innovations.
Q3 2024
Our active discussions to enter the UK market reflect our ambitious growth strategy, as we aim to bring our cutting-edge solutions to a broader audience and establish Aidplex as a key player in scoliosis monitoring across Europe. These efforts are driving our expansion and positioning us for long-term success in the international medical technology landscape.
Next Stage Challenge 2021 is over, and AidPlex is excited to announce that won 1st place at Prototype Stage! After 221 evaluations, AidPlex managed to win 1st place at the prototype stage as well as the impressions of the evaluators (investors and institutions).
The Hellenic Initiative (THI) announced the award winners of The 2021 Venture Impact Awards (VIA) on December 13 with a virtual event that presented one of THI’s newest programs, which the organization says helps and supports Greece’s brightest and most talented teams – for-profits and non-profits – in creating scalable and sustainable ventures and projects that create jobs.
Out of 15 Greek startups, AidPlex won 1st place for the best innovative idea in the Ecocity Forum 2018, an International Conference that took place on October 3-5, at Thessaloniki Concert Hall.
On 16/6/2022 the 12th organization of the competition “Innovation & Technology” took place. It is an initiative of the National Bank of Greece for the promotion of innovation, within the NBG Business Seeds program.